• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国前苏联出生的患者中耐多药和广泛耐药结核病的激增。

A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union.

机构信息

Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (National reference centre for mycobacteria and resistance of micobacteria to antituberculous drugs), Paris, France.

出版信息

Euro Surveill. 2013 Aug 15;18(33):20555. doi: 10.2807/1560-7917.es2013.18.33.20555.

DOI:10.2807/1560-7917.es2013.18.33.20555
PMID:23968874
Abstract

A marked increase in the number of multidrug-resistant (MDR) tuberculosis (TB) cases entirely related to patients born in the Former Soviet Union was observed in France in the last two years. Very few cases were clustered, suggesting it is a consequence of recent immigration of patients already infected in their country of origin. This major increase challenges the existing structures for management of MDR and extensively drug-resistant TB (XDR-TB).

摘要

在过去两年中,法国观察到耐多药(MDR)结核病(TB)病例数量显著增加,这些病例与出生在前苏联的患者完全相关。极少数病例呈聚集性,这表明这是最近原籍国已感染的患者移民的后果。这种大幅增加对管理耐多药和广泛耐药结核病(XDR-TB)的现有结构构成了挑战。

相似文献

1
A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union.法国前苏联出生的患者中耐多药和广泛耐药结核病的激增。
Euro Surveill. 2013 Aug 15;18(33):20555. doi: 10.2807/1560-7917.es2013.18.33.20555.
2
Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries.希腊的耐多药/广泛耐药结核病:前苏联国家流行的结核分枝杆菌基因型占主导地位。
Clin Microbiol Infect. 2017 Dec;23(12):1002-1004. doi: 10.1016/j.cmi.2017.07.002. Epub 2017 Jul 8.
3
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
4
Imported extensively drug-resistant Mycobacterium tuberculosis Beijing genotype, Marseilles, France, 2011.2011 年法国马赛流行的广泛耐药结核分枝杆菌北京基因型。
Euro Surveill. 2011 Apr 21;16(16):19846.
5
Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.预测耐多药和广泛耐药结核病复发的因素。
Int J Tuberc Lung Dis. 2012 Sep;16(9):1228-33. doi: 10.5588/ijtld.12.0037. Epub 2012 Jun 28.
6
Multidrug-resistant tuberculosis imported into low-incidence countries-a GeoSentinel analysis, 2008-2020.2008 年至 2020 年,低发病国家输入性耐多药结核病:一项 GeoSentinel 分析。
J Travel Med. 2021 Aug 27;28(6). doi: 10.1093/jtm/taab069.
7
Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.新型完全耐药结核杆菌的出现:伊朗的超级广泛耐药结核病或完全耐药菌株
Chest. 2009 Aug;136(2):420-425. doi: 10.1378/chest.08-2427. Epub 2009 Apr 6.
8
First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant in Saudi Arabia.沙特阿拉伯对耐多药菌氟喹诺酮和氨基糖苷类耐药性的首次洞察。
Am J Trop Med Hyg. 2017 May;96(5):1066-1070. doi: 10.4269/ajtmh.16-0579.
9
Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.挪威的耐多药结核病:一项1995 - 2014年的全国性研究
Int J Tuberc Lung Dis. 2016 Jun;20(6):786-92. doi: 10.5588/ijtld.15.0895.
10
Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.通过直接测序从痰涂片阳性样本中早期检测耐多药和广泛耐药前结核病
BMC Infect Dis. 2017 Apr 24;17(1):300. doi: 10.1186/s12879-017-2409-6.

引用本文的文献

1
Patient-centered approach to the management of drug-resistant tuberculosis in France: How far off the mark are we?法国以患者为中心的耐多药结核病管理方法:我们偏离目标有多远?
PLOS Glob Public Health. 2022 Apr 20;2(4):e0000313. doi: 10.1371/journal.pgph.0000313. eCollection 2022.
2
Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.修订的结核病耐药和治疗结果定义,法国,2006-2019 年。
Emerg Infect Dis. 2022 Sep;28(9):1796-1804. doi: 10.3201/eid2809.220458.
3
Multidrug-resistant tuberculosis imported into low-incidence countries-a GeoSentinel analysis, 2008-2020.
2008 年至 2020 年,低发病国家输入性耐多药结核病:一项 GeoSentinel 分析。
J Travel Med. 2021 Aug 27;28(6). doi: 10.1093/jtm/taab069.
4
Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.五个国家引入贝达喹啉治疗耐多药结核病的实例。
Int J Tuberc Lung Dis. 2017 Feb 1;21(2):167-174. doi: 10.5588/ijtld.16.0493.
5
Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rhône Alpes Region, France.法国罗纳-阿尔卑斯地区结核分枝杆菌遗传多样性的基因型、系统发育和流行病学综合分析
PLoS One. 2016 Apr 29;11(4):e0153580. doi: 10.1371/journal.pone.0153580. eCollection 2016.
6
Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014.2009 - 2014年法国药物和手术治疗广泛耐药结核病的初步良好结果
Emerg Infect Dis. 2016 Mar;22(3):518-21. doi: 10.3201/eid2203.151130.
7
Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?利奈唑胺在耐多药结核病起始联合方案中的应用:是否该进入第四组?
Open Forum Infect Dis. 2015 Dec 22;2(4):ofv175. doi: 10.1093/ofid/ofv175. eCollection 2015 Dec.
8
Map the gap: missing children with drug-resistant tuberculosis.找出差距:耐药结核病患儿情况不明问题
Public Health Action. 2015 Mar 21;5(1):45-58. doi: 10.5588/pha.14.0100.
9
Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.格鲁吉亚耐多药结核病患者失访的相关危险因素。
Public Health Action. 2014 Oct 21;4(Suppl 2):S41-6. doi: 10.5588/pha.14.0048.
10
Multi drug and other forms of drug resistant tuberculosis are uncommon among treatment naïve tuberculosis patients in Tanzania.在坦桑尼亚,初治结核病患者中耐多药和其他形式的耐药结核病并不常见。
PLoS One. 2015 Apr 7;10(4):e0118601. doi: 10.1371/journal.pone.0118601. eCollection 2015.